A gain-of-function mutation in adenylate cyclase confers isoflurane resistance in caenorhabditis elegans

Anesthesiology

Volumn 115, Issue 6, 2011, Pages 1162-1171

  Saifee, Owais ^a   Metz, Laura B ^b   Nonet, Michael L ^a   Crowder, C Michael ^b  

^a Division of Biology and Biomedical Sciences   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ALDICARB; CYCLIC AMP; ISOFLURANE; NEUROTRANSMITTER; SYNTAXIN;

ANIMAL EXPERIMENT; ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE MAPPING; GENE SEQUENCE; LOCOMOTION; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PARASITE ISOLATION; PHENOTYPE; PRIORITY JOURNAL;

ACETYLCHOLINE; ADENYLATE CYCLASE; ALDICARB; ALLELES; ANESTHETICS, INHALATION; ANIMALS; CAENORHABDITIS ELEGANS; CHROMOSOME MAPPING; DRUG RESISTANCE; ISOFLURANE; MUTATION; QA-SNARE PROTEINS; SYNAPTIC TRANSMISSION;

EID: 81855221743     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318239355d     Document Type: Article

References (51)

1. Hemmings HC Jr: Sodium channels and the synaptic mechanisms of inhaled anaesthetics. Br J Anaesth 2009; 103:61-9
2. Wu XS, Sun JY, Evers AS, Crowder M, Wu LG: Isoflurane inhibits transmitter release and the presynaptic action potential. ANESTHESIOLOGY 2004; 100:663-70
3. Crowder CM, Shebester LD, Schedl T: Behavioral effects of volatile anesthetics in Caenorhabditis elegans. ANESTHESIOLOGY 1996; 85:901-12
4. Franks NP, Lieb WR: Selective actions of volatile general anaesthetics at molecular and cellular levels [published erratum appears in Br J Anaesth 1993;71:616].
5. Br J Anaesth 1993; 71:65-76
6. van Swinderen B, Saifee O, Shebester L, Roberson R, Nonet ML, Crowder CM: A neomorphic syntaxin mutation blocks volatile-anesthetic action in Caenorhabditis elegans. Proc Natl Acad Sci USA 1999; 96:2479-84
7. Sudhof TC: The synaptic vesicle cycle. Annu Rev Neurosci 2004; 27:509-47
8. Hawasli AH, Saifee O, Liu C, Nonet ML, Crowder CM: Resistance to volatile anesthetics by mutations enhancing excitatory neurotransmitter release in Caenorhabditis elegans. Genetics 2004; 168:831-43
9. Wang ZW, Saifee O, Nonet ML, Salkoff L: SLO-1 potassium channels control quantal content of neurotransmitter release at the C. elegans neuromuscular junction. Neuron 2001; 32:867-81
10. Brenner S: The genetics of Caenorhabditis elegans. Genetics 1974; 77:71-94
11. Mello CC, Kramer JM, Stinchcomb D, Ambros V: Efficient gene transfer in C. elegans: Extrachromosomal maintenance and integration of transforming sequences. EMBO J 1991; 10:3959-70
12. Korswagen HC, van der Linden AM, Plasterk RH: G protein hyperactivation of the Caenorhabditis elegans adenylyl cyclase SGS-1 induces neuronal degeneration. Embo J 1998; 17:5059-65
13. Fisher CL, Pei GK: Modification of a PCR-based site-directed mutagenesis method. Biotechniques 1997; 23:570-1, 574
14. Parent CA, Devreotes PN: Constitutively active adenylyl cyclase mutant requires neither G proteins nor cytosolic regulators. J Biol Chem 1996; 271:18333-6
15. Korswagen HC, Park JH, Ohshima Y, Plasterk RH: An activating mutation in a Caenorhabditis elegans Gs protein induces neural degeneration. Genes Dev 1997; 11:1493-503
16. Anderson P: Mutagenesis, Caenorhabditis elegans: Modern Biological Analysis of an Organism. Edited by Epstein H, Shakes D. San Diego, Academic Press, 1995, pp 31-58
17. Herman RK, Horvitz HR: Genetic analysis of Caenorhabditis elegans, Nematodes as Biological Models. Edited by Zuckerman BM. New York, Academic Press, 1980; pp 227-61
18. Wicks SR, Yeh RT, Gish WR, Waterston RH, Plasterk RH: Rapid gene mapping in Caenorhabditis elegans using a high density polymorphism map. Nat Genet 2001; 28:160-4
19. Staunton J, Ganetzky B, Nonet ML: Rabphilin potentiates soluble N-ethylmaleimide sensitive factor attachment protein receptor function independently of rab3. J Neurosci 2001; 21:9255-64
20. Mahoney TR, Luo S, Nonet ML: Analysis of synaptic transmission in Caenorhabditis elegans using an aldicarb-sensitivity assay. Nat Protoc 2006; 1:1772-7
21. van Swinderen B, Metz LB, Shebester LD, Crowder CM: A Caenorhabditis elegans pheromone antagonizes volatile anesthetic action through a go-coupled pathway. Genetics 2002; 161:109-19
22. Horton JK, Martin RC, Kalinka S, Cushing A, Kitcher JP, O'Sullivan MJ, Baxendale PM: Enzyme immunoassays for the estimation of adenosine 3′,5′ cyclic monophosphate and guanosine 3′,5′ cyclic monophosphate in biological fluids. J Immunol Methods 1992; 155:31-40
23. Hanahan D: Studies on transformation of Escherichia coli with plasmids. J Mol Biol 1983; 166:557-80
24. Waud DR: On biological assays involving quantal responses. J Pharmacol Exp Ther 1972; 183:577-607
25. Schade MA, Reynolds NK, Dollins CM, Miller KG: Mutations that rescue the paralysis of Caenorhabditis elegans ric-8 (synembryn) mutants activate the G alpha(s) pathway and define a third major branch of the synaptic signaling network. Genetics 2005; 169:631-49
26. Reynolds NK, Schade MA, Miller KG: Convergent, RIC-8-dependent Galpha signaling pathways in the Caenorhabditis elegans synaptic signaling network. Genetics 2005; 169: 651-70
27. Seino S, Shibasaki T: PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiol Rev 2005; 85:1303-42
28. Berger AJ, Hart AC, Kaplan JM: G alphas-induced neurodegeneration in Caenorhabditis elegans. J Neurosci 1998; 18: 2871-80
29. Jansen G, Thijssen KL, Werner P, van der Horst M, Hazendonk E, Plasterk RH: The complete family of genes encoding G proteins of Caenorhabditis elegans. Nat Genet 1999; 21: 414-9
30. Hanoune J, Defer N: Regulation and role of adenylyl cyclase isoforms. Annu Rev Pharmacol Toxicol 2001; 41:145-74
31. Benito E, Barco A: CREB's control of intrinsic and synaptic plasticity: Implications for CREB-dependent memory models. Trends Neurosci 2010; 33:230-40
32. Sutton KG, McRory JE, Guthrie H, Murphy TH, Snutch TP: P/Q-type calcium channels mediate the activity-dependent feedback of syntaxin-1A. Nature 1999; 401:800-4
33. Bates EA, Victor M, Jones AK, Shi Y, Hart AC: Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity. J Neurosci 2006; 26: 2830-8
34. van Swinderen B, Metz LB, Shebester LD, Mendel JE, Sternberg PW, Crowder CM: Goalpha regulates volatile anesthetic action in Caenorhabditis elegans. Genetics 2001; 158:643-55
35. Metz LB, Dasgupta N, Liu C, Hunt SJ, Crowder CM: An evolutionarily conserved presynaptic protein is required for isoflurane sensitivity in Caenorhabditis elegans. ANESTHESIOLOGY 2007; 107:971-82
36. Richmond JE, Davis WS, Jorgensen EM: UNC-13 is required for synaptic vesicle fusion in C. elegans. Nat Neurosci 1999; 2:959-64
37. Richmond JE, Weimer RM, Jorgensen EM: An open form of syntaxin bypasses the requirement for UNC-13 in vesicle priming. Nature 2001; 412:338-41
38. Madison JM, Nurrish S, Kaplan JM: UNC-13 interaction with syntaxin is required for synaptic transmission. Curr Biol 2005; 15:2236-42
39. Rizo J, Rosenmund C: Synaptic vesicle fusion. Nat Struct Mol Biol 2008; 15:665-74
40. Wang Y, Okamoto M, Schmitz F, Hofmann K, Südhof TC: Rim is a putative Rab3 effector in regulating synaptic-vesicle fusion. Nature 1997; 388:593-8
41. Castillo PE, Schoch S, Schmitz F, Südhof TC, Malenka RC: RIM1alpha is required for presynaptic long-term potentiation. Nature 2002; 415:327-30
42. Lonart G, Schoch S, Kaeser PS, Larkin CJ, Südhof TC, Linden DJ: Phosphorylation of RIM1alpha by PKA triggers presynaptic long-term potentiation at cerebellar parallel fiber synapses. Cell 2003; 115:49-60
43. Betz A, Thakur P, Junge HJ, Ashery U, Rhee JS, Scheuss V, Rosenmund C, Rettig J, Brose N: Functional interaction of the active zone proteins Munc13-1 and RIM1 in synaptic vesicle priming. Neuron 2001; 30:183-96
44. Deng L, Kaeser PS, Xu W, Südhof TC: RIM proteins activate vesicle priming by reversing autoinhibitory homodimerization of Munc13. Neuron 2011; 69:317-31
45. Pernía-Andrade A, Jonas P: The multiple faces of RIM. Neuron 2011; 69:185-7
46. 2+ channels to presynaptic active zones via a direct PDZ-domain interaction. Cell 2011; 144: 282-95
47. Aravamudan B, Broadie K: Synaptic Drosophila UNC-13 is regulated by antagonistic G-protein pathways via a proteasome-dependent degradation mechanism. J Neurobiol 2003; 54:417-38
48. Richmond J: Synaptic function. WormBook 2005; 1-14
49. Herring BE, Xie Z, Marks J, Fox AP: Isoflurane inhibits the neurotransmitter release machinery. J Neurophysiol 2009; 102:1265-73
50. Rosenmund C, Sigler A, Augustin I, Reim K, Brose N, Rhee JS: Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. Neuron 2002; 33:411-24
51. Augustin I, Betz A, Herrmann C, Jo T, Brose N: Differential expression of two novel Munc13 proteins in rat brain. Biochem J 1999; 337:363-71